U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT06942299) titled 'A Study of AK0529 in Adults Patients Hospitalized With RSV Infection' on March 24, 2023.
Brief Summary: This is a randomized, double-blind, placebo-controlled, multicenter, phase II study to be conducted in adults hospitalized with RSV infection in China. The main objectives of this study are to investigate the safety, pharmacokinetics and efficacy of AK0529 in adult RSV patients.
Study Start Date: July 20, 2023
Study Type: INTERVENTIONAL
Condition:
Respiratory Syncytial Virus Infections
Intervention:
DRUG: AK0529
Active Substance: AK0529, Pharmaceutical Form: Enteric pellets, Route of Administration: Oral, fasting
DRUG: AK...